Cancer

Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium

JERUSALEM, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the…

1 year ago

Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area

OSAKA, Japan and MONTREAL , Dec. 5, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; "Ono") announced that…

1 year ago

InvestiQuant Makes Donation to iCCARE for Children with Cancer

RALEIGH, N.C., Dec. 5, 2024 /PRNewswire/ -- InvestiQuant, a leading provider of AI-driven, alternative investment solutions, proudly announces the success…

1 year ago

Lunit and Volpara Unveiled Unified Ecosystem at RSNA 2024 to Transform Global Cancer Care

Lunit and Volpara revealed a unified Ecosystem at RSNA 2024, featuring AI-powered cancer risk prediction, autonomous report generation, and innovations…

1 year ago

IceCure’s ProSense® Cryoablation Safe and Effective in Destruction of Kidney Tumors with 88.7% Recurrence-Free Rate Based on Interim ICESECRET Study Results

Data confirm previous results showing that ProSense® cryoablation is highly effective for kidney tumors < 3 cm and a safe…

1 year ago

Theator Takes the Gold in the First of its Kind Critical View of Safety Challenge at MICCAI 2024, Demonstrating Excellence in AI-Driven Surgical Safety

Theator's advanced AI technology sets a new standard in surgical safety, outperforming competitors in the SAGES CVS Challenge and showcasing…

1 year ago

Vevo Therapeutics to Release World’s Largest Atlas of Single-Cell Transcriptomic Data, Tahoe-100M, to Map How Drugs Impact Patient Cells and Accelerate Discovery of New Drugs

Vevo's Mosaic platform is the first to make single-cell measurement of drug action across heterogeneous patients scalable The Tahoe-100M dataset,…

1 year ago

Article about Canalevia-CA1, Jaguar Health’s Prescription Drug Conditionally Approved by the FDA for the Treatment of Chemotherapy-Induced Diarrhea in Dogs, Published in PetVet Magazine

Canalevia&reg;-CA1 is a canine-specific formulation of crofelemer, Jaguar's novel, oral plant-based drug sustainably harvested from the Croton lechleri treeCrofelemer, the…

1 year ago

CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 2024

Live webcast discussion featuring internationally renowned Glioblastoma Multiforme (GBM) Key Opinion LeadersCompany committed to addressing the most aggressive type of…

1 year ago